Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jan 24;7(2):280-282.
doi: 10.1182/bloodadvances.2022008846.

DOACs for VTE in patients with brain cancer and brain metastases: choices, choices, choices

Richard J Buka  1 , David J Sutton  2
Affiliations
Comment

DOACs for VTE in patients with brain cancer and brain metastases: choices, choices, choices

Richard J Buka et al. Blood Adv. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: R.J.B. has received research funding from AstraZeneca; D.S. received speaker fees from Pfizer, Bristol Myers Squibb, and Bayer.

Comment in

Comment on

References

    1. Giustozzi M, Proietti G, Becattini C, et al. ICH in patients with primary or metastatic brain cancer treated or not with anticoagulants: a systematic review and meta-analysis. Blood Adv. 2022;6(16):4873–4883. - PMC - PubMed
    1. Agnelli G, Becattini C, Meyer G, et al. Apixaban for the treatment of venous thromboembolism associated with cancer. N Engl J Med. 2020;382(17):1599–1607. - PubMed
    1. McBane RD, Wysokinski WE, Le-Rademacher JG, et al. Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial. J Thromb Haemostasis. 2020;18(2):411–421. - PubMed
    1. Young AM, Marshall A, Thirlwall J, et al. Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D) J Clin Oncol. 2018;36(20):2017–2023. - PubMed
    1. Raskob GE, Van Es N, Verhamme P, et al. Edoxaban for the treatment of cancer-associated venous thromboembolism. N Engl J Med. 2018;378(7):615–624. - PubMed

MeSH terms